Published in Cancer J Sci Am on December 30, 1999
Chemotherapy for ovarian cancer: beyond paclitaxel plus carboplatin. Cancer J Sci Am (1999) 0.75
Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 15.05
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
Stimulation of bone formation in vitro and in rodents by statins. Science (1999) 5.55
Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature (2000) 4.93
Environment and development. Earth system science for global sustainability: grand challenges. Science (2010) 3.92
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
Age-dependent impairment of angiogenesis. Circulation (1999) 3.47
Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology (2000) 2.99
Rab11 is required for trans-golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor. Mol Biol Cell (1998) 2.86
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol (1999) 2.83
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79
Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem (2001) 2.74
Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry (2001) 2.74
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med (1997) 2.73
Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli. J Biol Chem (2000) 2.58
Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem (1997) 2.57
The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev (1999) 2.52
Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J (1998) 2.45
Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery. Blood (1997) 2.44
Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med (1997) 2.31
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest (2003) 2.30
Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol (1998) 2.29
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation (1998) 2.25
Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer (1997) 2.20
The role of water stress in the inactivation of messenger RNA of germinating wheat embryos. Proc Natl Acad Sci U S A (1968) 2.15
X-ray spectra estimation using attenuation measurements from 25 kVp to 18 MV. Med Phys (1999) 2.11
Formulation and physical characterization of large porous particles for inhalation. Pharm Res (1999) 2.10
Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med (1996) 2.08
Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J Biol Chem (1995) 2.06
Hormone replacement therapy in breast cancer survivors: a cohort study. Am J Obstet Gynecol (1996) 2.04
The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J Pharmacol Exp Ther (1970) 2.01
Three-dimensional visualization of the rotavirus hemagglutinin structure. Cell (1993) 1.95
Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol (1998) 1.95
Funding Canada's health care system: a tax-based alternative to privatization. CMAJ (1998) 1.92
Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science (1994) 1.88
Protection against vaginal SIV transmission with microencapsulated vaccine. Science (1993) 1.86
Genetic diversity of Pierce's disease strains and other pathotypes of Xylella fastidiosa. Appl Environ Microbiol (2001) 1.85
MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone (2004) 1.79
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol (1992) 1.77
Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst (1996) 1.76
Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. Biochemistry (1998) 1.75
Workshop to identify critical windows of exposure for children's health: immune and respiratory systems work group summary. Environ Health Perspect (2000) 1.74
Helical nanofilament phases. Science (2009) 1.71
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol (1997) 1.70
Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol Cell Biol (1997) 1.69
Early ribosomal RNA transcription and appearance of cytoplasmic ribosomes during germination of the wheat embryo. Nat New Biol (1971) 1.68
Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob Agents Chemother (2000) 1.67
Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med (1990) 1.66
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Multimers formed by the rotavirus nonstructural protein NSP2 bind to RNA and have nucleoside triphosphatase activity. J Virol (1999) 1.65
Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents. Curr Med Chem (2005) 1.65
Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy (2009) 1.64
Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients. J Clin Microbiol (1999) 1.61
Negative regulation of the heat shock transcriptional response by HSBP1. Genes Dev (1998) 1.61
Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect (2000) 1.60
Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem (2000) 1.59
Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J Biol Chem (1999) 1.56
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. J Natl Cancer Inst (2010) 1.55
Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem (1998) 1.54
Initiation of nucleolar assembly is independent of RNA polymerase I transcription. Mol Biol Cell (2000) 1.54
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest (1996) 1.52
Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. Immunity (1997) 1.52
Genetic susceptibility to benzene and shortened gestation: evidence of gene-environment interaction. Am J Epidemiol (2000) 1.52
Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther (1975) 1.52
Isolation of the gene encoding the Drosophila melanogaster homolog of the Saccharomyces cerevisiae GCN2 eIF-2alpha kinase. Genetics (1998) 1.51
Vasculitis and retinoids. Lancet (1989) 1.49
Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol Cell Biol (1994) 1.46
Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull World Health Organ (1990) 1.45
Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study) Am J Obstet Gynecol (1989) 1.44
Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury. Am J Transplant (2011) 1.43
15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst (2000) 1.43
Dose response analysis of pilocarpine-induced ocular hypotension. Arch Ophthalmol (1970) 1.40
Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J Neurosci (1997) 1.40
A neuronal ryanodine receptor mediates light-induced phase delays of the circadian clock. Nature (1998) 1.39
Anisotropy and corotation of galactic cosmic rays. Science (2006) 1.39
Hormone replacement therapy in breast cancer. Lancet (1993) 1.39
Comment on "Identification of monochloro-nonabromodiphenyl ethers in the air and soil samples from South China". Environ Sci Technol (2011) 1.38
Ureteric bud cells secrete multiple factors, including bFGF, which rescue renal progenitors from apoptosis. Am J Physiol (1997) 1.38
Sudden death associated with aortitis and fibrosclerosing disease of the conduction system. Arch Pathol Lab Med (1992) 1.38
Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine (2010) 1.37
Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol (1997) 1.37
Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant (2007) 1.34
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations. Leukemia (2010) 1.34
MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo. Breast Cancer Res Treat (1995) 1.34
Human immunodeficiency virus type 1 nef quasispecies in pathological tissue. J Virol (1992) 1.33
Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. Cancer Res (1988) 1.33
Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2. J Bone Miner Res (1999) 1.33
Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. Gynecol Oncol (2000) 1.33
Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. Biochem Biophys Res Commun (1998) 1.32
Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun (1998) 1.32
15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res (2000) 1.31
VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. EMBO J (1992) 1.30
Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc Natl Acad Sci U S A (1998) 1.29
The effects of cytokines and growth factors on osteoblastic cells. Bone (1995) 1.28
Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol (2000) 1.28
A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept (2001) 1.26
Dietary associations in a case-control study of endometrial cancer. Cancer Causes Control (1993) 1.26